The changing face of chronic illness management in primary care: A qualitative study of underlying influences and unintended outcomes

Linda M. Hunt, Meta Kreiner, Howard Brody

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

PURPOSE Recently, there has been dramatic increase in the diagnosis and pharmaceutical management of common chronic illnesses. Using qualitative data collected in primary care clinics, we assessed how these trends play out in clinical care. METHODS This qualitative study focused on management of type 2 diabetes and hypertension in 44 primary care clinics in Michigan and was based on interviews with 58 clinicians and 70 of their patients, and observations of 107 clinical consultations. We assessed clinicians' treatment strategies and discussions of factors influencing treatment decisions, and patients' understandings and experiences in managing these illnesses. RESULTS Clinicians focused on helping patients achieve test results recommended by national guidelines, and most reported combining 2 or more medications per condition to reach targets. Medication selection and management was the central focus of the consultations we observed. Polypharmacy was common among patients, with more than one-half taking 5 or more medications. Patient interviews indicated that heavy reliance on pharmaceuticals presents challenges to patient well-being, including financial costs and experiences of adverse health effects. CONCLUSIONS Factors promoting heavy use of pharmaceuticals include lower diagnostic and treatment thresholds, clinician-auditing and reward systems, and the prescribing cascade, whereby more medications are prescribed to control the effects of already-prescribed medications. We present a conceptual model, the inverse benefit law, to provide insight into the impact of pharmaceutical marketing efforts on the observed trends. We make recommendations about limiting the influence of the pharmaceutical industry on clinical practice, toward improving the well-being of patients with chronic illness.

Original languageEnglish (US)
Pages (from-to)452-460
Number of pages9
JournalAnnals of Family Medicine
Volume10
Issue number5
DOIs
StatePublished - Sep 2012

Fingerprint

Primary Health Care
Chronic Disease
Pharmaceutical Preparations
Referral and Consultation
Interviews
Polypharmacy
Drug Industry
Marketing
Reward
Type 2 Diabetes Mellitus
Therapeutics
Guidelines
Hypertension
Costs and Cost Analysis
Health

Keywords

  • Chronic illness
  • Clinical practice guidelines
  • Diabetes mellitus
  • Drug therapy
  • Hypertension
  • Pharmaceutical marketing
  • Physician incentive programs
  • Polypharmacy
  • Prescribing patterns, physician

ASJC Scopus subject areas

  • Family Practice

Cite this

The changing face of chronic illness management in primary care : A qualitative study of underlying influences and unintended outcomes. / Hunt, Linda M.; Kreiner, Meta; Brody, Howard.

In: Annals of Family Medicine, Vol. 10, No. 5, 09.2012, p. 452-460.

Research output: Contribution to journalArticle

@article{238c81693f6c4675982392ebb2d14922,
title = "The changing face of chronic illness management in primary care: A qualitative study of underlying influences and unintended outcomes",
abstract = "PURPOSE Recently, there has been dramatic increase in the diagnosis and pharmaceutical management of common chronic illnesses. Using qualitative data collected in primary care clinics, we assessed how these trends play out in clinical care. METHODS This qualitative study focused on management of type 2 diabetes and hypertension in 44 primary care clinics in Michigan and was based on interviews with 58 clinicians and 70 of their patients, and observations of 107 clinical consultations. We assessed clinicians' treatment strategies and discussions of factors influencing treatment decisions, and patients' understandings and experiences in managing these illnesses. RESULTS Clinicians focused on helping patients achieve test results recommended by national guidelines, and most reported combining 2 or more medications per condition to reach targets. Medication selection and management was the central focus of the consultations we observed. Polypharmacy was common among patients, with more than one-half taking 5 or more medications. Patient interviews indicated that heavy reliance on pharmaceuticals presents challenges to patient well-being, including financial costs and experiences of adverse health effects. CONCLUSIONS Factors promoting heavy use of pharmaceuticals include lower diagnostic and treatment thresholds, clinician-auditing and reward systems, and the prescribing cascade, whereby more medications are prescribed to control the effects of already-prescribed medications. We present a conceptual model, the inverse benefit law, to provide insight into the impact of pharmaceutical marketing efforts on the observed trends. We make recommendations about limiting the influence of the pharmaceutical industry on clinical practice, toward improving the well-being of patients with chronic illness.",
keywords = "Chronic illness, Clinical practice guidelines, Diabetes mellitus, Drug therapy, Hypertension, Pharmaceutical marketing, Physician incentive programs, Polypharmacy, Prescribing patterns, physician",
author = "Hunt, {Linda M.} and Meta Kreiner and Howard Brody",
year = "2012",
month = "9",
doi = "10.1370/afm.1380",
language = "English (US)",
volume = "10",
pages = "452--460",
journal = "Annals of Family Medicine",
issn = "1544-1709",
publisher = "Annals of Family Medicine, Inc",
number = "5",

}

TY - JOUR

T1 - The changing face of chronic illness management in primary care

T2 - A qualitative study of underlying influences and unintended outcomes

AU - Hunt, Linda M.

AU - Kreiner, Meta

AU - Brody, Howard

PY - 2012/9

Y1 - 2012/9

N2 - PURPOSE Recently, there has been dramatic increase in the diagnosis and pharmaceutical management of common chronic illnesses. Using qualitative data collected in primary care clinics, we assessed how these trends play out in clinical care. METHODS This qualitative study focused on management of type 2 diabetes and hypertension in 44 primary care clinics in Michigan and was based on interviews with 58 clinicians and 70 of their patients, and observations of 107 clinical consultations. We assessed clinicians' treatment strategies and discussions of factors influencing treatment decisions, and patients' understandings and experiences in managing these illnesses. RESULTS Clinicians focused on helping patients achieve test results recommended by national guidelines, and most reported combining 2 or more medications per condition to reach targets. Medication selection and management was the central focus of the consultations we observed. Polypharmacy was common among patients, with more than one-half taking 5 or more medications. Patient interviews indicated that heavy reliance on pharmaceuticals presents challenges to patient well-being, including financial costs and experiences of adverse health effects. CONCLUSIONS Factors promoting heavy use of pharmaceuticals include lower diagnostic and treatment thresholds, clinician-auditing and reward systems, and the prescribing cascade, whereby more medications are prescribed to control the effects of already-prescribed medications. We present a conceptual model, the inverse benefit law, to provide insight into the impact of pharmaceutical marketing efforts on the observed trends. We make recommendations about limiting the influence of the pharmaceutical industry on clinical practice, toward improving the well-being of patients with chronic illness.

AB - PURPOSE Recently, there has been dramatic increase in the diagnosis and pharmaceutical management of common chronic illnesses. Using qualitative data collected in primary care clinics, we assessed how these trends play out in clinical care. METHODS This qualitative study focused on management of type 2 diabetes and hypertension in 44 primary care clinics in Michigan and was based on interviews with 58 clinicians and 70 of their patients, and observations of 107 clinical consultations. We assessed clinicians' treatment strategies and discussions of factors influencing treatment decisions, and patients' understandings and experiences in managing these illnesses. RESULTS Clinicians focused on helping patients achieve test results recommended by national guidelines, and most reported combining 2 or more medications per condition to reach targets. Medication selection and management was the central focus of the consultations we observed. Polypharmacy was common among patients, with more than one-half taking 5 or more medications. Patient interviews indicated that heavy reliance on pharmaceuticals presents challenges to patient well-being, including financial costs and experiences of adverse health effects. CONCLUSIONS Factors promoting heavy use of pharmaceuticals include lower diagnostic and treatment thresholds, clinician-auditing and reward systems, and the prescribing cascade, whereby more medications are prescribed to control the effects of already-prescribed medications. We present a conceptual model, the inverse benefit law, to provide insight into the impact of pharmaceutical marketing efforts on the observed trends. We make recommendations about limiting the influence of the pharmaceutical industry on clinical practice, toward improving the well-being of patients with chronic illness.

KW - Chronic illness

KW - Clinical practice guidelines

KW - Diabetes mellitus

KW - Drug therapy

KW - Hypertension

KW - Pharmaceutical marketing

KW - Physician incentive programs

KW - Polypharmacy

KW - Prescribing patterns, physician

UR - http://www.scopus.com/inward/record.url?scp=84866176725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866176725&partnerID=8YFLogxK

U2 - 10.1370/afm.1380

DO - 10.1370/afm.1380

M3 - Article

C2 - 22966109

AN - SCOPUS:84866176725

VL - 10

SP - 452

EP - 460

JO - Annals of Family Medicine

JF - Annals of Family Medicine

SN - 1544-1709

IS - 5

ER -